Acadian Asset Management’s Cogent Biosciences COGT Stock Holding History

Acadian Asset Management’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$530K	Sell	13,814 -1,503	-10%	-$55.5K	﹤0.01%	1342
2025 Q4	$543K	Buy	+15,317	New	+$431K	﹤0.01%	1287
2024 Q4	–	Sell	-3,320	Closed	-$35K	–	1719
2024 Q3	$35K	Buy	+3,320	New	+$32.3K	﹤0.01%	1893
2021 Q2	–	Sell	-610	Closed	-$5K	–	2027
2021 Q1	$5K	Buy	+610	New	+$5.87K	﹤0.01%	2020
2020 Q4	–	Sell	-80,759	Closed	-$757K	–	2218
2020 Q3	$757K	Sell	80,759 -6,203	-7%	-$64.7K	﹤0.01%	1007
2020 Q2	$161K	Buy	86,962 +56,278	+183%	+$104K	﹤0.01%	1563
2020 Q1	$51K	Hold	30,684	–	–	﹤0.01%	1498
2019 Q4	$88K	Buy	30,684 +18,939	+161%	+$77.3K	﹤0.01%	1502
2019 Q3	$68K	Buy	11,745 +3,595	+44%	+$29.2K	﹤0.01%	1567
2019 Q2	$85K	Buy	8,150 +4,679	+135%	+$62.3K	﹤0.01%	1397
2019 Q1	$61K	Buy	+3,471	New	+$59.3K	﹤0.01%	1633

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Acadian Asset Management's COGT Position: Q1 2026 in Review

Acadian Asset Management reduced its Cogent Biosciences (COGT) stake by 9.8% in Q1 2026, selling an estimated $55.5K and leaving 13,814 shares worth $530K. The position accounts for ﹤0.01% of the portfolio, ranked #1342.

Acadian Asset Management first reported a position in COGT in Q1 2019 and has held it in 11 quarters since. The position peaked at $757K in Q3 2020. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

Acadian Asset Management held 13,814 shares of Cogent Biosciences worth $530K as of Q1 2026.
Acadian Asset Management sold 1,503 Cogent Biosciences shares in Q1 2026, an estimated $55.5K.
Cogent Biosciences made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1342 holding.
Acadian Asset Management first reported a position in Cogent Biosciences in Q1 2019 and has held it in 11 quarters since.
Acadian Asset Management's Cogent Biosciences position peaked at $757K in Q3 2020.
305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.